Table 2.
Effect of the antagonists on baseline vascular tone (FVR, absolute value, mean±s.e.)
Mean±s.e. | Saline | Antagonist |
---|---|---|
Indomethacin* | 53±9 | 61±9 |
TEA* | 30±2 | 62±13 |
Glibenclamide | 56±11 | 47±6 |
Glibenclamide (low-dose ATP) | 44±5 | 49±9 |
Ouabain* | 49±6 | 63±9 |
T+l+L* | 34±8 | 92±10 |
T+l+L* (SNP) | 48±3 | 85±10 |
T=TEA; I=indomethacin; L=L-NMMA;
:P<0.05 for baseline versus antagonist (paired t-test)